O	0	7	Hypoxia	Hypoxia	NN	B-NP
O	7	8	-	-	HYPH	O
O	8	18	responsive	responsive	JJ	B-NP
O	19	26	element	element	NN	I-NP
O	26	27	-	-	HYPH	B-VP
O	27	35	mediated	mediate	VBN	B-NP
O	36	43	soluble	soluble	JJ	I-NP
O	44	48	Tie2	Tie2	NN	I-NP
O	49	55	vector	vector	NN	I-NP
O	56	64	exhibits	exhibit	VBZ	B-VP
O	65	67	an	an	DT	B-NP
O	68	72	anti	anti	AFX	I-NP
O	72	73	-	-	HYPH	I-NP
O	73	83	angiogenic	angiogenic	JJ	I-NP
O	84	92	activity	activity	NN	I-NP
O	93	95	in	in	FW	B-ADVP
O	96	101	vitro	vitro	FW	I-ADVP
O	102	107	under	under	IN	B-PP
O	108	115	hypoxic	hypoxic	JJ	B-NP
O	116	125	condition	condition	NN	I-NP
O	125	126	.	.	.	O

O	127	134	Hypoxia	Hypoxia	NN	B-NP
O	134	135	-	-	HYPH	O
O	135	144	inducible	inducible	JJ	B-NP
O	145	151	factor	factor	NN	I-NP
O	151	152	-	-	HYPH	B-NP
O	152	153	1	1	CD	I-NP
O	154	155	(	(	(	O
O	155	158	HIF	HIF	NN	B-NP
O	158	159	-	-	HYPH	B-NP
O	159	160	1	1	CD	I-NP
O	160	161	)	)	)	O
O	162	164	is	be	VBZ	B-VP
O	165	168	one	one	CD	B-NP
O	169	171	of	of	IN	B-PP
O	172	175	the	the	DT	B-NP
O	176	179	key	key	JJ	I-NP
O	180	189	mammalian	mammalian	JJ	I-NP
O	190	203	transcription	transcription	NN	I-NP
O	204	211	factors	factor	NNS	I-NP
O	212	215	and	and	CC	O
O	216	221	shows	show	NNS	B-NP
O	222	231	increased	increase	VBN	B-VP
O	232	238	levels	level	NNS	B-NP
O	239	241	in	in	IN	B-PP
O	242	246	both	both	CC	O
O	247	254	protein	protein	NN	B-NP
O	255	264	stability	stability	NN	I-NP
O	265	268	and	and	CC	O
O	269	278	intrinsic	intrinsic	JJ	B-NP
O	279	294	transcriptional	transcriptional	JJ	I-NP
O	295	303	activity	activity	NN	I-NP
O	304	310	during	during	IN	B-PP
O	311	314	low	low	JJ	B-NP
O	315	321	oxygen	oxygen	NN	I-NP
O	322	329	tension	tension	NN	I-NP
O	329	330	.	.	.	O

O	331	338	Hypoxia	Hypoxia	NN	B-NP
O	338	339	-	-	HYPH	O
O	339	348	activated	activate	VBN	B-VP
O	349	359	functional	functional	JJ	B-NP
O	360	363	HIF	HIF	NN	I-NP
O	363	364	-	-	HYPH	B-NP
O	364	365	1	1	CD	I-NP
O	366	373	protein	protein	NN	I-NP
O	374	379	binds	bind	VBZ	B-VP
O	380	382	to	to	TO	B-PP
O	383	390	hypoxia	hypoxia	NN	B-NP
O	390	391	-	-	HYPH	B-NP
O	391	401	responsive	responsive	JJ	I-NP
O	402	410	elements	element	NNS	I-NP
O	411	412	(	(	(	O
O	412	415	HRE	HRE	NN	B-NP
O	415	416	)	)	)	O
O	417	419	in	in	IN	B-PP
O	420	423	the	the	DT	B-NP
O	424	433	enhancers	enhancer	NNS	I-NP
O	434	436	of	of	IN	B-PP
O	437	444	several	several	JJ	B-NP
O	445	450	genes	gene	NNS	I-NP
O	451	460	including	include	VBG	B-PP
O	461	465	VEGF	VEGF	NN	B-NP
O	465	466	,	,	,	O
O	467	470	the	the	DT	B-NP
O	471	476	major	major	JJ	I-NP
O	477	483	player	player	NN	I-NP
O	484	486	in	in	IN	B-PP
O	487	499	angiogenesis	angiogenesis	NN	B-NP
O	499	500	,	,	,	O
O	501	504	and	and	CC	O
O	505	514	initiates	initiate	VBZ	B-VP
O	515	520	their	their	PRP$	B-NP
O	521	525	mRNA	mRNA	NN	I-NP
O	526	536	expression	expression	NN	I-NP
O	536	537	.	.	.	O

O	538	541	The	The	DT	B-NP
O	542	551	molecular	molecular	JJ	I-NP
O	552	562	mechanisms	mechanism	NNS	I-NP
O	563	573	regulating	regulate	VBG	B-VP
O	574	577	the	the	DT	B-NP
O	578	582	gene	gene	NN	I-NP
O	583	593	expression	expression	NN	I-NP
O	594	599	under	under	IN	B-PP
O	600	607	hypoxic	hypoxic	JJ	B-NP
O	608	618	conditions	condition	NNS	I-NP
O	619	624	could	could	MD	B-VP
O	625	633	increase	increase	VB	I-VP
O	634	637	the	the	DT	B-NP
O	638	649	therapeutic	therapeutic	JJ	I-NP
O	650	656	window	window	NN	I-NP
O	657	659	of	of	IN	B-PP
B-Cancer	660	665	tumor	tumor	NN	B-NP
O	665	666	-	-	HYPH	B-NP
O	666	674	specific	specific	JJ	I-NP
O	675	683	delivery	delivery	NN	I-NP
O	684	691	systems	system	NNS	I-NP
O	691	692	.	.	.	O

O	693	695	In	In	IN	B-PP
O	696	700	this	this	DT	B-NP
O	701	706	study	study	NN	I-NP
O	706	707	,	,	,	O
O	708	710	to	to	TO	B-VP
O	711	718	examine	examine	VB	I-VP
O	719	726	hypoxia	hypoxia	NN	B-NP
O	726	727	-	-	HYPH	B-NP
O	727	735	specific	specific	JJ	I-NP
O	736	746	production	production	NN	I-NP
O	747	749	of	of	IN	B-PP
O	750	754	anti	anti	AFX	B-NP
O	754	755	-	-	HYPH	I-NP
O	755	765	angiogenic	angiogenic	JJ	I-NP
O	766	777	therapeutic	therapeutic	JJ	I-NP
O	778	782	gene	gene	NN	I-NP
O	782	783	,	,	,	O
O	784	786	we	we	PRP	B-NP
O	787	798	constructed	construct	VBD	B-VP
O	799	800	5	5	CD	B-NP
O	801	807	copies	copy	NNS	I-NP
O	808	810	of	of	IN	B-PP
O	811	814	HRE	HRE	NN	B-NP
O	815	816	(	(	(	O
O	816	821	5xHRE	5xHRE	NN	B-NP
O	821	822	)	)	)	O
O	823	825	of	of	IN	B-PP
O	826	831	human	human	JJ	B-NP
O	832	836	VEGF	VEGF	NN	I-NP
O	837	843	linked	link	VBN	B-VP
O	844	846	to	to	TO	B-PP
O	847	854	soluble	soluble	JJ	B-NP
O	855	859	Tie2	Tie2	NN	I-NP
O	860	861	(	(	(	O
O	861	866	sTie2	sTie2	NN	B-NP
O	866	867	)	)	)	O
O	868	874	driven	drive	VBN	B-VP
O	875	877	by	by	IN	B-PP
O	878	885	minimal	minimal	JJ	B-NP
O	886	890	SV40	SV40	NN	I-NP
O	891	899	promoter	promoter	NN	I-NP
O	900	901	(	(	(	O
O	901	906	5xHRE	5xHRE	NN	B-NP
O	906	907	/	/	SYM	B-NP
O	907	911	SV40	SV40	NN	I-NP
O	911	912	/	/	SYM	I-NP
O	912	917	sTie2	sTie2	NN	I-NP
O	917	918	)	)	)	O
O	918	919	.	.	.	O

O	920	923	Our	Our	PRP$	B-NP
O	924	928	data	datum	NNS	I-NP
O	929	935	showed	show	VBD	B-VP
O	936	940	that	that	IN	B-SBAR
O	941	946	under	under	IN	B-PP
O	947	954	hypoxia	hypoxia	NN	B-NP
O	955	958	the	the	DT	B-NP
O	959	967	secreted	secrete	VBN	I-NP
O	968	973	sTie2	sTie2	NN	I-NP
O	974	985	selectively	selectively	RB	B-ADVP
O	986	995	inhibited	inhibit	VBD	B-VP
B-Tissue	996	1000	tube	tube	NN	B-NP
O	1001	1010	formation	formation	NN	I-NP
O	1011	1014	and	and	CC	I-NP
O	1015	1024	migration	migration	NN	I-NP
O	1025	1035	capacities	capacity	NNS	I-NP
O	1036	1038	of	of	IN	B-PP
B-Cell	1039	1050	endothelial	endothelial	JJ	B-NP
I-Cell	1051	1056	cells	cell	NNS	I-NP
O	1057	1059	in	in	FW	B-ADVP
O	1060	1065	vitro	vitro	FW	I-ADVP
O	1065	1066	.	.	.	O

O	1067	1072	Hence	Hence	RB	B-ADVP
O	1072	1073	,	,	,	O
O	1074	1076	we	we	PRP	B-NP
O	1077	1084	propose	propose	VBP	B-VP
O	1085	1089	that	that	IN	B-SBAR
O	1090	1093	the	the	DT	B-NP
O	1094	1100	vector	vector	NN	I-NP
O	1101	1107	system	system	NN	I-NP
O	1107	1108	,	,	,	O
O	1109	1114	5xHRE	5xHRE	NN	B-NP
O	1114	1115	/	/	SYM	B-NP
O	1115	1119	SV40	SV40	NN	I-NP
O	1119	1120	/	/	SYM	I-NP
O	1120	1125	sTie2	sTie2	NN	I-NP
O	1125	1126	,	,	,	O
O	1127	1132	might	might	MD	B-VP
O	1133	1135	be	be	VB	I-VP
O	1136	1137	a	a	DT	B-NP
O	1138	1144	useful	useful	JJ	I-NP
O	1145	1149	tool	tool	NN	I-NP
O	1150	1153	for	for	IN	B-PP
O	1154	1158	down	down	RB	B-ADVP
O	1158	1159	-	-	HYPH	B-NP
O	1159	1169	regulating	regulate	VBG	B-VP
B-Cancer	1170	1175	tumor	tumor	NN	B-NP
O	1176	1188	angiogenesis	angiogenesis	NN	I-NP
O	1189	1194	under	under	IN	B-PP
O	1195	1202	hypoxic	hypoxic	JJ	B-NP
O	1203	1212	condition	condition	NN	I-NP
O	1212	1213	.	.	.	O

